ArticleOncotarget2018
Bcl-2 inhibition sensitizes triple-negative human breast cancer cells to doxorubicin.
Touko Inao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
48 papers cite it
this papercites it
ArticleOncotarget2018
Touko Inao et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.